Additional studies are needed to assess the impact of geriatric assessment in patients receiving oral cancer treatment, more particularly EGFR TKIs and also to identify geriatric parameters associated with tolerance and/or survival. This evidence concerns the gene EGFR and lip and oral cavity carcinoma.